Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study
Oral Diseases · 2025
DOI: 10.1111/odi.15364 ↗At a glance
Journal article in Oral Diseases, 2025. Written by Erica Quagliarini and 9 co-authors. Institution: NanoDelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Major MEDLINE topics: Mouth Neoplasms, Carcinoma, Squamous Cell, Nanotechnology, Protein Corona. 48 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objective
To address the limitations and complexities associated with tissue biopsy, emerging nanotechnology methods show promise in enhancing the detection and management of oral squamous cell carcinoma and oral potential malignant disorders. Among them, the characterization of the protein corona, the biomolecular layer that envelops materials when exposed to biological fluids, has recently emerged as a powerful tool for distinguishing oncological patients from healthy people. Materials and Methods Building upon recent insights, here we formulated a new diagnostic method for oral squamous cell carcinoma and oral potentially malignant disorders based on the characterization of the personalized protein corona formed on graphene oxide nanosheets when exposed to the plasma of the patients.
Results
The findings highlighted a discernible distinction between oncological subjects and healthy ones, resulting in an overall accuracy of 87%. Subsequently, we applied this method to monitor the progression of the diseases of the patients undergoing treatment, and we observed a trend indicating a convergence of protein profiles between oncological patients and healthy subjects throughout the treatment course.
Conclusion
If further confirmed in larger prospective studies, this new approach could discriminate oral squamous cell carcinoma and oral potentially malignant disorders and can be considered in the management of these oral diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- NanoDelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
- Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy.
- Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
ORCID profiles: Federica Rocchetti
Cite
APA
Quagliarini, E., Caracciolo, G., Giulimondi, F., Rocchetti, F., Tenore, G., Borghetti, L., Ottini, L., Valentini, V., Polimeni, A., & Romeo, U. (2025). Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study. Oral Diseases. https://doi.org/10.1111/odi.15364
Vancouver
Quagliarini E, Caracciolo G, Giulimondi F, Rocchetti F, Tenore G, Borghetti L, et al. Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study. Oral Diseases. 2025. doi:10.1111/odi.15364
BibTeX
@article{Quagliarini2025,
author = {Quagliarini, Erica and Caracciolo, Giulio and Giulimondi, Francesca and Rocchetti, Federica and Tenore, Gianluca and Borghetti, Lucia and Ottini, Laura and Valentini, Valentino and Polimeni, Antonella and Romeo, Umberto},
title = {Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15364}
}
EUVIMED